Effect of Oral Fluconazole 1200 Mg/Day on QT Interval in African Adults With HIV-associated Cryptococcal Meningitis

AIDS - United States
doi 10.1097/qad.0000000000001961
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults With Cryptococcal Meningitis.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Emerging Concepts in HIV-associated Cryptococcal Meningitis

Current Opinion in Infectious Diseases
Infectious DiseasesMicrobiology
2019English

Factors Associated With Early Mycological Clearance in HIV-associated Cryptococcal Meningitis

PLoS ONE
Multidisciplinary
2017English

Recent Advances in Managing HIV-associated Cryptococcal Meningitis

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2019English

Combined Therapy With Fluconazole and Flucytosine in Murine Cryptococcal Meningitis.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1991English

Ophthalmic Signs in Ugandan Adults With HIV-associated Cryptococcal Meningitis: A Nested Analysis of the ASTRO-CM Cohort

Wellcome Open Research
BiochemistryMedicineGeneticsMolecular Biology
2018English

Dynamic Ploidy Changes Drive Fluconazole Resistance in Human Cryptococcal Meningitis

Journal of Clinical Investigation
Medicine
2019English

Risk Factors in HIV/AIDS Patients With Cryptococcal Meningitis

BMC Infectious Diseases
Infectious Diseases
2014English

The Use of Mannitol in HIV-infected Patients With Symptomatic Cryptococcal Meningitis

Drug discoveries & therapeutics
MedicineToxicologyPharmaceuticsPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy